Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$23.28
-1.09-4.47%
Last update: Sep 24, 10:00 AM
Beam Therapeutics Inc (BEAM) Stock Price, Quote, News & History
BEAMNASDAQ
Beam Therapeutics (BEAM) Stock Price, Quote, News & History | Benzinga
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Beam Therapeutics (BEAM) stock?
You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.
Who are Beam Therapeutics (BEAM) competitors?
Other companies in Beam Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Beam Therapeutics (BEAM) stock?
Beam Therapeutics has a consensus price target of $49.43.
What is the current price for Beam Therapeutics (BEAM)?
The stock price for Beam Therapeutics (NASDAQ: BEAM) is $23.2801 last updated September 24, 2026 at 10:00 AM EDT.
Does Beam Therapeutics (BEAM) pay a dividend?
There are no upcoming dividends for Beam Therapeutics.
When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?
Beam Therapeutics does not have any upcoming earnings scheduled.
Is Beam Therapeutics (BEAM) going to split?
There is no upcoming split for Beam Therapeutics.
What sector and industry does Beam Therapeutics (BEAM) operate in?
Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
